End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring.

Wang, R; Foskey, R; Barmanray, R; Le, B; Fourlanos, S

End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring.

Wang, R Foskey, R Barmanray, R Le, B

Fourlanos, S

Permalink

Publisher:: MARY ANN LIEBERT, INC
Publication Type:: Journal Article
Citation:: J Palliat Med, 2022, 25, (3), pp. 516-518
Issue Date:: 2022-03

Closed Access

	Filename	Description	Size
	jpm.2021.0271.pdf	Published version	55.1 kB		View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wang, R
dc.contributor.author	Foskey, R
dc.contributor.author	Barmanray, R
dc.contributor.author	Le, B https://orcid.org/0000-0002-0830-4864
dc.contributor.author	Fourlanos, S
dc.date.accessioned	2023-06-12T05:48:29Z
dc.date.available	2023-06-12T05:48:29Z
dc.date.issued	2022-03
dc.identifier.citation	J Palliat Med, 2022, 25, (3), pp. 516-518
dc.identifier.issn	1096-6218
dc.identifier.issn	1557-7740
dc.identifier.uri	http://hdl.handle.net/10453/170705
dc.description.abstract	Use of medical device technologies for diabetes mellitus, including continuous glucose monitoring devices, is becoming more frequently encountered in end-of-life care. Good communication is paramount to determine patient and carer preferences for if, when, and how blood glucose monitoring should occur in the end-of-life setting. We present two differing cases of how continuous glucose monitoring in an Australian setting impacted end-of-life care for the patients and their carers.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	MARY ANN LIEBERT, INC
dc.relation.ispartof	J Palliat Med
dc.relation.isbasedon	10.1089/jpm.2021.0271
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1110 Nursing, 1117 Public Health and Health Services
dc.subject.classification	Gerontology
dc.subject.mesh	Australia
dc.subject.mesh	Blood Glucose
dc.subject.mesh	Blood Glucose Self-Monitoring
dc.subject.mesh	Hospice Care
dc.subject.mesh	Humans
dc.subject.mesh	Palliative Care
dc.subject.mesh	Terminal Care
dc.subject.mesh	Humans
dc.subject.mesh	Blood Glucose
dc.subject.mesh	Blood Glucose Self-Monitoring
dc.subject.mesh	Palliative Care
dc.subject.mesh	Terminal Care
dc.subject.mesh	Hospice Care
dc.subject.mesh	Australia
dc.subject.mesh	Australia
dc.subject.mesh	Blood Glucose
dc.subject.mesh	Blood Glucose Self-Monitoring
dc.subject.mesh	Hospice Care
dc.subject.mesh	Humans
dc.subject.mesh	Palliative Care
dc.subject.mesh	Terminal Care
dc.title	End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring.
dc.type	Journal Article
utslib.citation.volume	25
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
utslib.for	1110 Nursing
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2023-06-12T05:48:28Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	25
utslib.citation.issue	3

Abstract:

Use of medical device technologies for diabetes mellitus, including continuous glucose monitoring devices, is becoming more frequently encountered in end-of-life care. Good communication is paramount to determine patient and carer preferences for if, when, and how blood glucose monitoring should occur in the end-of-life setting. We present two differing cases of how continuous glucose monitoring in an Australian setting impacted end-of-life care for the patients and their carers.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/170705